Monday , November 20 2017
Home / Resources / Products / ITCA650 -12 month Dose GLP-1 Treatment

ITCA650 -12 month Dose GLP-1 Treatment

 

ITCA 650 A 1 year implant dose of exenatide in type 2 diabetes shows positive results. See item #6 for more information.

 

 

 

 

 

 

See more GLP-1 Agonist Resources